860 The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model

• Kyong Hwa Park,
• Eunkyo Joung,
• Hunwoo Shin,
• Hun Jung,
• Jinho Kang,
• Byung cheol Ahn,
• Eunjung Jung

Affiliations

Kyong Hwa Park

Korea University, Seoul, South Korea

Eunkyo Joung

2Aston Sci. Inc., Seoul, Korea, Republic of

Hunwoo Shin

2Aston Sci. Inc., Seoul, Korea, Republic of

Hun Jung

2Aston Sci. Inc., Seoul, Korea, Republic of

Jinho Kang

1Korea University College of Medicine, Seoul, Korea, Republic of

Byung cheol Ahn

4CHA Vaccine Institute, Seoul, Korea, Republic of

Eunjung Jung

4CHA Vaccine Institute, Seoul, Korea, Republic of